Just one day after President Donald Trump harangued Pfizer CEO Ian Read into delaying its drug pricing hikes, the pharma giant has announced it’s splitting up into three business units: innovative medicines, established medicines, and consumer healthcare.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,